| Literature DB >> 2765373 |
D J Webster1, D Flook, J Jenkins, A Hutchings, P A Routledge.
Abstract
The acetylator phenotype was determined in 100 patients with breast cancer and 100 control female subjects using isoniazid. The proportion of fast acetylators in the breast cancer patients (43%) was not significantly different from the control group (43%). We conclude that acetylator phenotype is unlikely to be an important determinant of the risk of developing breast cancer.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2765373 PMCID： PMC2247050 DOI： 10.1038/bjc.1989.260
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640